Literature DB >> 2972670

In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.

C Watanakunakorn1.   

Abstract

Twenty strains of coagulase-negative staphylococci (18 strains of Staphylococcus haemolyticus and two of S. epidermidis) were serially subcultured in broth media containing subinhibitory concentrations (half the MIC) of either vancomycin or teicoplanin. The MIC of the antibiotic was again measured after five passages in antibiotic-containing broth. The organisms were then subcultured in broth containing antibiotic concentrations half of the new MIC value. The experiment was terminated after 25 passages. Only one strain developed a four-fold increase in vancomycin MIC. On the other hand, 16 strains developed four-fold MIC increases to teicoplanin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972670     DOI: 10.1093/jac/22.3.321

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

3.  In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis.

Authors:  L Herwaldt; L Boyken; M Pfaller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

4.  Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.

Authors:  F Brunet; G Vedel; F Dreyfus; J F Vaxelaire; T Giraud; B Schremmer; J F Monsallier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

5.  Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.

Authors:  G Vedel; M Leruez; F Lémann; E Hraoui; D Ratovohery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

6.  In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  J G Barr; E T Smyth; G M Hogg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

7.  Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.

Authors:  F Biavasco; C Vignaroli; R Lazzarini; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Authors:  J R Aeschlimann; G P Allen; E Hershberger; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 9.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 10.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.